Andrew Glashow, Chairman and CEO of CLS Holdings, was a panelist on “The ROI of Manufactured Cannabis Products vs Plain Old Flower” at Benzinga’s Cannabis Capital Conference. Glashow shared that when the founders of his company decided to get into the cannabis industry, there was this overarching question of cannabis cultivation or cannabis manufacturing.
Eventually, the company decided to venture into manufacturing because they believed it offered more margin and more opportunities than flower would. While he shares that the decision didn’t reap benefits at first, as flower prices have dropped, manufacturing has proven to be a viable option.
Interested in learning more about the Benzinga Cannabis Capital Conference? Get more information here.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
